Chuanlu Shen Selected Research

Peroxiredoxins

2/2002

Nonredundant antioxidant defense by multiple two-cysteine peroxiredoxins in human prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chuanlu Shen Research Topics

Disease

3	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2017
2	Neoplasms (Cancer) 01/2024 - 01/2022
2	Squamous Cell Carcinoma of Head and Neck 01/2023 - 01/2022
1	Facial Paralysis (Facial Palsy) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 02/2002

Drug/Important Bio-Agent (IBA)

1	MicroRNAs (MicroRNA)IBA 01/2024
1	Ion Channels (Ion Channel)IBA 01/2022
1	Long Noncoding RNAIBA 01/2020
1	PlatinumIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	KinesinsIBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	caffeic acid phenethyl esterIBA 11/2017
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 11/2017
1	CalciumIBA 05/2017
1	Oncogene Proteins (Oncogene Protein)IBA 05/2017
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2017
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 05/2017
1	AntibodiesIBA 02/2002
1	Cysteine (L-Cysteine)FDA Link 02/2002
1	PeroxiredoxinsIBA 02/2002
1	Protein Isoforms (Isoforms)IBA 02/2002
1	Proteins (Proteins, Gene)FDA Link 02/2002
1	AntioxidantsIBA 02/2002
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2002

Therapy/Procedure

1	Therapeutics 01/2023
1	Immunotherapy 01/2022
1	Rhytidoplasty (Facelift) 01/2022